Table 2. Distribution of apoE polymorphism among patients with ESRD and controls.
| Studies | ESRD |
Control |
Hardy–Weinberg equilibrium | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ε2ε2 | ε2ε3 | ε2ε4 | ε3ε3 | ε3ε4 | ε4ε4 | ε2ε2 | ε2ε3 | ε2ε4 | ε3ε3 | ε3ε4 | ε4ε4 | |||
| Feussner/1992 | 8 | 60 | 18 | 346 | 117 | 11 | 10 | 124 | 15 | 617 | 236 | 29 | Yes | |
| Olmer/1997 | 1 | 8 | 1 | 41 | 15 | 0 | 3 | 40 | 4 | 231 | 54 | 6 | Yes | |
| Fumitake/1997 | 0 | 10 | 2 | 66 | 19 | 1 | 0 | 15 | 0 | 131 | 24 | 3 | Yes | |
| Eggertsen/1997 | 0 | 2 | 3 | 30 | 14 | 2 | 4 | 42 | 14 | 239 | 65 | 43 | No | |
| Kohlmeier/1998 | 7 | 31 | 1 | 139 | 39 | 2 | 10 | 124 | 15 | 617 | 236 | 29 | Yes | |
| Oda/1999 | 1 | 50 | 4 | 347 | 82 | 1 | 2 | 35 | 4 | 414 | 111 | 10 | Yes | |
| Choi/1999 | 0 | 8 | 0 | 37 | 9 | 0 | 0 | 16 | 0 | 147 | 31 | 0 | Yes | |
| Imura/1999 | 0 | 53 | 0 | 350 | 90 | 0 | 0 | 41 | 0 | 316 | 65 | 0 | No | |
| Guz/2000 | 4 | 33 | 2 | 200 | 28 | 2 | 33 | 887 | 67 | 6208 | 1079 | 92 | No | |
| Jana/2002 | 1 | 9 | 3 | 63 | 11 | 0 | 0 | 9 | 1 | 44 | 12 | 1 | Yes | |
| Asakimori/2003 | 1 | 21 | 1 | 109 | 31 | 0 | 2 | 35 | 4 | 414 | 111 | 10 | Yes | |
| Roussos/2004 | 1 | 49 | 9 | 215 | 96 | 15 | 1 | 42 | 9 | 181 | 101 | 9 | Yes | |
| Liberopoulos /2004 | 5 | 28 | 3 | 224 | 40 | 1 | 0 | 21 | 2 | 128 | 44 | 5 | Yes | |
| Huang/2005 | 4 | 30 | 7 | 47 | 6 | 0 | 2 | 15 | 4 | 76 | 11 | 0 | Yes | |
| Arikan/2007 | 1 | 18 | 4 | 107 | 12 | 2 | 1 | 3 | 0 | 36 | 2 | 0 | Yes | |
| Fahad/2008 | 0 | 4 | 1 | 33 | 3 | 1 | 0 | 3 | 0 | 35 | 11 | 1 | Yes | |